Benralizamab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets.

The U.S. pharmaceutical industry seeks to alter Medicare drug price negotiation laws under Trump's return. China approves ...

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...

A new study where injections were used to treat severe asthma has shown promising results. But experts say more needs to be ...

The global IgA Nephropathy Disease Treatment Market is at the forefront of addressing the growing burden of renal diseases worldwide. With a projected value surpassing USD 485 million by 2028, the ...

We are grateful to our colleagues for their interest and thoughtful comments on our Seminar about systemic lupus erythematosus (SLE).1 We appreciate the remarks from Qihe Xu, and Thomas Pabst and ...

Request To Download Sample of This Strategic Report @ Rising cases of thyroid cancer is expected to drive the market. According to National Cancer Institute about 1.2% of men and women are detected ...

More than five million people in the UK suffer from asthma, but a new drug called benralizumab could change the game.

A new study, supported by AstraZeneca, has shown that a single dose of benralizumab significantly reduces treatment failure ...

AstraZeneca's (NASDAQ:AZN) blockbuster cancer medication, Enhertu, developed with Japanese pharma giant Daiichi Sankyo (OTCPK ...

Pfizer Inc. (NYSE: PFE), and AstraZeneca plc (NASDAQ: AZN) may have faded from the spotlight since the peak of the COVID-19 ...